Investment firm Gilde Healthcare has closed its latest fund, which features Royal Philips as cornerstone investor and Johnson & Johnson as a limited partner.

Netherlands-based healthcare investment firm Gilde Healthcare closed its latest fund at €250m ($280m) today after securing electronics and healthcare technology producer Royal Philips as cornerstone investor.

Johnson & Johnson Innovation – JJDC, the corporate venturing arm of healthcare group Johnson & Johnson, also contributed to Gilde Healthcare IV, as did European Investment Fund, which participated through funding initiatives including European Recovery Program and Dutch Venture Initiative II.

Other limited partners for the fund include state-owned funds like Danish Growth Fund…